NCT04975334View on ClinicalTrials.gov

Opioid Antagonism in Hypogonadotropic Hypogonadism

PHASE1RecruitingINTERVENTIONAL

Enrollment

23

Participants

Timeline

Start Date

June 18, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Hypogonadotropic HypogonadismLow Testosterone

Interventions

DRUG

Naloxone

One bolus of naloxone

Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital, Boston

All Listed Sponsors

lead

Stephanie B. Seminara, MD

OTHER